Ascendis Pharma director Jean-Jacques Bienaime buys USD 492,079 of common shares
Reuters2026/08/19 01:03Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Ascendis Pharma director Jean Jacques Bienaime bought 2,000 ordinary shares in open-market purchases.
- Purchases were executed at weighted-average prices of USD 245.85 and USD 246.91.
- Bienaime’s direct holding rose to 2,900 ordinary shares following the transactions.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000360), on August 18, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SM Prime Holdings Target Price Raised to PHP39.50 From PHP38.00 by Maybank Securities >SMPH.PH
Dow Jones•2026/08/19 05:09
FACC FY26 H1 EBIT climbs 38% to EUR 25.3 million; revenue rises 8.6% to EUR 526.3 million
Reuters•2026/08/19 05:08
MOL signs lease for four berths at expanded Kobe International Container Terminal
Reuters•2026/08/19 05:07
